IP Library Granted Patent US 12,534,719
Granted Patent B2
US 12,534,719 · App. 18/208,770 · Granted Jan 27, 2026

Nucleic acid sequencing adapters and uses thereof

Inventors: Eric Andrew Evans (Brisbane, CA); Imran Saeedul Haque (San Francisco, CA); Kyle Beauchamp (San Francisco, CA); Clement Chu (South San Francisco, CA); Carlo G. Artieri (San Bruno, CA); Noah Welker (Half Moon Bay, CA)
Assignee: Myriad Women's Health, Inc.
C12N15/1093C12N9/1252C12Q1/6806C12Q1/6832C12Q1/6869C12N15/10C12P19/34C12Q2525/191C12Q2527/107C12Q2563/179C12Y207/07007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,534,719
App. No.
18/208,770
Granted
Jan 27, 2026
Kind
B2
Abstract

High-fidelity, high-throughput nucleic acid sequencing enables healthcare practitioners and patients to gain insight into genetic variants and potential health risks. However, previous methods of nucleic acid sequencing often introduces sequencing errors (for example, mutations that arise during the preparation of a nucleic acid library, during amplification, or sequencing). Provided herein are sequencing adapters comprising a nondegenerate or variable length molecular barcode and compositions comprising a plurality of sequencing adapters, which can be useful for sequencing nucleic acids. Further provided are methods of using the sequencing adapters, including methods of sequencing nucleic acids, methods of identifying an error in a nucleic acid sequence, and methods of determining the number of nucleic acid molecules in a library.

Claims (106)

1 . A method of constructing an error-corrected duplex nucleic consensus sequence, comprising:

ligating a first sequencing adapter and a second sequencing adaptor to a duplex nucleic acid molecule, wherein the first sequencing adaptor comprises a first duplex molecular barcode comprising n base positions, wherein the second sequencing adaptor comprises a second duplex molecular barcode comprising n+x base positions, wherein the second duplex molecular barcode has more base positions than the first duplex molecular barcode, and wherein x is not zero;

amplifying a first strand of the duplex nucleic acid molecule and a second stand of the duplex nucleic acid molecule thereby producing a set of amplified first strands and a set of amplified second strands;

sequencing the set of amplified first strands thereby producing a set of first strand reads;

sequencing the set of amplified second strands thereby producing a set of second strand reads;

constructing a first strand consensus sequence using the set of first strand reads;

constructing a second strand consensus sequence using the set of second strand reads;

comparing the first strand consensus sequence to the second strand consensus sequence;

removing errors in the set of first strand reads and the set of second strand reads; and

constructing an error-corrected duplex nucleic consensus sequence.

2 . The method of claim 1 , wherein the first sequencing adapter is a U-shaped sequence adapter or a Y-shaped sequence adapter,

wherein the first duplex molecular barcode further comprises a predetermined base fraction at one or more base positions across a plurality of duplex molecular barcodes,

wherein the n of the first duplex molecular barcode is between 8 and 16,

wherein the second sequencing adapter is a U-shaped sequence adapter or a Y-shaped sequence adapter, and

wherein the second duplex molecular barcode further comprises a predetermined base fraction at one or more base positions across the plurality of molecular barcodes,

wherein the n of the second duplex molecular barcode is between 8 and 16 and the x is 1,

wherein the second duplex molecular barcode has more base positions than the first duplex molecular barcode,

wherein the first sequence adapter and the second sequence adaptor comprise a first constant 3′-overhang comprising a thymine residue directly adjacent to the first and second duplex molecular barcode, and

wherein for each duplex molecular barcode other than the first duplex molecular barcode a thymine residue does not immediately precede the first constant 3′-overhang of each sequence adapter.

3 . The method of claim 1 , wherein the first strand is sequenced in a first direction and a second direction, and wherein the second strand is sequenced in a first direction and a second direction.

4 . The method of claim 1 , wherein the duplex nucleic acid molecule is a cell-free DNA molecule selected from a cell-free tumor DNA molecule or a cell-free fetal DNA molecule.

5 . The method of claim 1 , further comprising enriching the duplex nucleic acid molecule from a nucleic acid library using a set of capture probes for a region of interest.

6 . The method of claim 5 , wherein the set of capture probes are balanced, wherein a balanced set of capture probes provide a reduced sequencing depth variance relative to a set of capture probes comprising a plurality of approximately equally represented capture probes.

7 . The method of claim 6 , further comprising preparing the balanced set of capture probes, wherein the preparing comprises:

sequencing a reference sequencing library comprising a plurality of nucleic acid molecules enriched using a first set of capture probes, wherein each capture probe comprises a sequence that is substantially complementary to a portion of or adjacent to a region of interest included in the reference sequencing library, and wherein an initial known amount of each capture probe is used to form the first set of capture probes;

determining a sequencing depth attributable to each capture probe in the set of capture probes;

selecting a subsequent known amount of each capture probe based on the initial known amount and the sequencing depth attributable to each capture probe, wherein the subsequent known amount of each capture probe is selected thereby minimizing a difference between a predicted sequencing depth profile and a desired sequencing depth profile; and

constructing the balanced set of capture probes by combining at least a fraction of the capture probes at the subsequent known amount of each capture probe in the balanced set of capture probes.

8 . The method of claim 7 , wherein the minimizing a difference is constrained by a minimum subsequent amount or a maximum subsequent amount of each capture probe.

9 . The method of claim 7 , wherein the desired sequencing depth profile is uniform.

10 . The method of claim 7 , wherein the desired sequencing depth profile is non-uniform.

11 . The method of claim 7 , wherein the difference between the predicted sequencing depth profile and the desired sequencing depth profile is defined or implied by an objective function.

12 . The method of claim 7 , wherein the initial known amount is selected from an initial known volume an initial known mass or an initial known number of moles, and the subsequent known amount is selected from a subsequent known volume, a subsequent known mass or a subsequent known number of moles.

13 . The method of any one of claim 7 , wherein the initial known amount is an initial known relative amount, and the subsequent known amount is a subsequent known relative amount.

14 . The method of claim 13 , wherein each capture probe is not substantially complementary to overlapping portions of the region of interest.

15 . The method of claim 13 , wherein at least two of each capture probe in the plurality of capture probes are substantially complementary to overlapping portions of the region of interest.

16 . The method of claim 13 , further comprising obtaining for each capture probe a binding fraction based on the sequencing depth attributable to the capture probe; and wherein the subsequent known amount is based on the initial known amount and the binding fraction.

17 . The method of claim 16 , wherein obtaining the binding fraction further comprises approximating the sequencing depth for a given capture probe i as a Poisson distribution:

d is =Poisson( N s π i )

wherein:

d is the determined sequencing depth attributable to the capture probe i;

N s is the number of nucleic acid molecules in reference sequencing library s; and

π i is the binding fraction for capture probe i.

18 . The method of claim 17 , further comprising determining π i by fitting a maximum likelihood model or a Markov chain Monte Carlo model.

19 . The method of claim 13 , further comprising obtaining for each capture probe a binding fraction, wherein the binding fraction is determined for the fraction of nucleic acid molecules comprising a segment substantially complementary to at least half of the each capture probe based on the sequencing depth attributable to the capture probe; and

wherein the subsequent known amount is based on the initial known amount and the fraction.

20 . The method of claim 13 , further comprising defining the difference by an objective function of the subsequent amounts of each capture probes in the balanced set of capture probes, according to:

f

(

v

)

=

V

(

π

(

v

)

)

wherein

:

(

π

(

v

)

)

i

=

(

1

+

γ

i

v

i

c

i

)

-

1

wherein:

V( ) is a user-defined objective function for the set of capture probes;

({right arrow over (π)}({right arrow over (v)})) i is the binding fraction for capture probe i for the vector ({right arrow over (π)}({right arrow over (v)}));

c i is an effective concentration for capture probe i for the vector (π i ({right arrow over (v)}));

v i is the subsequent amount of capture probe i for the vector ({right arrow over (π)}({right arrow over (v)})); and

Y i is the initial amount of capture probe i for the vector (π i ({right arrow over (v)})).

21 . The method of claim 13 , further comprising preparing a re-balanced set of probes, wherein the preparing comprise:

enriching the reference sequencing library using the balanced set of capture probes thereby producing an enriched reference sequencing library;

sequencing the enriched reference sequencing library;

determining a sequencing depth attributable to each balanced capture probe;

selecting a second subsequent known amount of each capture probe based on the subsequent known amount of the each balanced capture probe and the sequencing depth attributable to each capture probe, wherein the second subsequent known amount of each capture probe is selected thereby minimizing a difference between a second predicted sequencing depth profile and the desired sequencing depth profile; and

constructing the re-balanced set of capture probes by combining at least a fraction of the capture probes at the second subsequent known amount of each capture probe in the re-balanced set of capture probes.

22 . The method of claim 21 , wherein the minimizing a difference is constrained by a minimum second subsequent amount or a maximum second subsequent amount of each capture probe.

23 . The method of claim 13 , wherein constructing the balanced set of capture probes further comprises combining each capture probe in the first set of capture probes at the subsequent known amount of each capture probe in the balanced set capture probe.

24 . The method of any one of claim 7 , wherein the sequencing depth is based on a number of sequencing reads that comprise a sequence substantially complementary to a sequence within each capture probe, or wherein the sequencing depth is based on a number of sequencing reads that comprise a sequence substantially complementary to at least half of each capture probe.

25 . The method of claim 24 , wherein the number of sequencing reads is a number of consensus sequencing reads or a number of duplex consensus sequencing reads.

Assignments (3)
SECURITY INTEREST Recorded Aug 1, 2025
From: MYRIAD GENETICS, INC.; MYRIAD GENETIC LABORATORIES, INC.; MYRIAD WOMEN’S HEALTH, INC.; ASSUREX HEALTH, INC.; GATEWAY GENOMICS, LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP, AS ADMINISTRATIVE AGENT FOR SECURED PARTIES
Reel/Frame 072309/0932 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2023
From: EVANS, ERIC ANDREW; HAQUE, IMRAN SAEEDUL; BEAUCHAMP, KYLE; CHU, CLEMENT; ARTIERI, CARLO O.; WELKER, NOAH
To: COUNSYL, INC.
Reel/Frame 064691/0761 →
CHANGE OF NAME Recorded Aug 24, 2023
From: COUNSYL, INC.
To: MYRIAD WOMEN'S HEALTH, INC.
Reel/Frame 064699/0962 →
Continuity (5)
Continuation 15619078 · Jun 9, 2017
Provisional Application 62447784 · Jan 18, 2017
Provisional Application 62348791 · Jun 10, 2016
Provisional Application 62364256 · Jul 19, 2016
Related Publication 20230416729A1 · Dec 28, 2023
References Cited (144)
US 5476930A · Letsinger et al. · 1995 [cited by applicant]
US 5695937A · Kinzler et al. · 1997 [cited by applicant]
US 5780613A · Letsinger et al. · 1998 [cited by applicant]
US 6258540B1 · Lo · 2001 [cited by applicant]
US 7109178B2 · Ji et al. · 2006 [cited by applicant]
US 7115400B1 · Adessi et al. · 2006 [cited by applicant]
US 7332277B2 · Dhallan · 2008 [cited by applicant]
US 7799531B2 · Mitchell et al. · 2010 [cited by applicant]
US 8383338B2 · Kitzman et al. · 2013 [cited by applicant]
US 9092401B2 · Richards et al. · 2015 [cited by applicant]
US 9309556B2 · Myllykangas et al. · 2016 [cited by applicant]
US 9476095B2 · Vogelstein et al. · 2016 [cited by applicant]
US 10752946B2 · Chu et al. · 2020 [cited by applicant]
US 20050164241A1 · Hahn et al. · 2005 [cited by applicant]
US 20070134658A1 · Bohmer · 2007 [cited by applicant]
US 20080160580A1 · Adessi et al. · 2008 [cited by applicant]
US 20080286795A1 · Kawashima et al. · 2008 [cited by applicant]
US 20090136938A1 · Tao et al. · 2009 [cited by applicant]
US 20100022406A1 · Srinivasan et al. · 2010 [cited by applicant]
US 20110319290A1 · Raymond et al. · 2011 [cited by applicant]
US 20120058468A1 · McKeown · 2012 [cited by applicant]
US 20120295819A1 · Leamon et al. · 2012 [cited by applicant]
US 20130157870A1 · Pushkarev et al. · 2013 [cited by applicant]
US 20130171185A1 · Settembre et al. · 2013 [cited by applicant]
US 20130261019A1 · Lin et al. · 2013 [cited by applicant]
US 20130298265A1 · Cunnac et al. · 2013 [cited by applicant]
US 20140024536A1 · Richards et al. · 2014 [cited by applicant]
US 20140024541A1 · Richards et al. · 2014 [cited by applicant]
US 20140121116A1 · Richards et al. · 2014 [cited by applicant]
US 20140141982A1 · Jacobson et al. · 2014 [cited by applicant]
US 20140162278A1 · Richards et al. · 2014 [cited by applicant]
US 20140180594A1 · Kim et al. · 2014 [cited by applicant]
US 20140274740A1 · Srinivasan et al. · 2014 [cited by applicant]
US 20150017635A1 · Myllykangas et al. · 2015 [cited by applicant]
US 20150044687A1 · Schmitt · 2015 [cited by examiner]
US 20150080266A1 · Volkmuth et al. · 2015 [cited by applicant]
US 20150197798A1 · Xu et al. · 2015 [cited by applicant]
US 20150205914A1 · Richards et al. · 2015 [cited by applicant]
US 20150275289A1 · Otwinowski et al. · 2015 [cited by applicant]
US 20150284712A1 · Kurihara et al. · 2015 [cited by applicant]
US 20150353926A1 · Rigatti et al. · 2015 [cited by applicant]
US 20150361492A1 · Vogelstein et al. · 2015 [cited by applicant]
US 20160068903A1 · Zhou et al. · 2016 [cited by applicant]
US 20160115544A1 · Elzinga · 2016 [cited by applicant]
US 20160152972A1 · Stapleton · 2016 [cited by examiner]
US 20160314242A1 · Schnall-Levin · 2016 [cited by examiner]
US 20160319345A1 · Gnerre et al. · 2016 [cited by applicant]
US 20170321270A1 · Haque et al. · 2017 [cited by applicant]
US 20170355984A1 · Evans et al. · 2017 [cited by applicant]
US 20180089364A1 · Muzzey et al. · 2018 [cited by applicant]
US 20180201994A1 · Beauchamp et al. · 2018 [cited by applicant]
US 20180216103A1 · Lai et al. · 2018 [cited by applicant]
US 20180216176A1 · Chu · 2018 [cited by applicant]
US 20180237837A1 · Osborne et al. · 2018 [cited by applicant]
CN 104232626 · 2014 [cited by applicant]
WO WO2010151842A2 · 2010 [cited by applicant]
WO WO2012003374A2 · 2012 [cited by applicant]
WO WO2012040387A1 · 2012 [cited by applicant]
WO WO2012078792A2 · 2012 [cited by applicant]
WO WO2012088456A2 · 2012 [cited by applicant]
WO WO2013112923A1 · 2013 [cited by applicant]
WO WO2013142389A1 · 2013 [cited by applicant]
WO WO2014144495A1 · 2014 [cited by applicant]
WO WO2015131107A1 · 2015 [cited by examiner]
WO WO2016010856A1 · 2016 [cited by applicant]
WO WO2016130704A2 · 2016 [cited by applicant]
WO WO2016176322A1 · 2016 [cited by examiner]
WO WO2016191272A1 · 2016 [cited by examiner]
WO WO2017037657A1 · 2017 [cited by applicant]
WO WO2018144216A1 · 2018 [cited by applicant]
WO WO2018144217A1 · 2018 [cited by applicant]
O'Roak et al. Science 2012. 338:1619-1622 and Supplementary Materials. (Year: 2012). [cited by examiner]
Ahn, J et al., Asymmetrical barcode adapter assisted recovery of duplicate reads and error correction strategy to detect rare mutations in circulating tumor DNA. Nature; May 2, 2017; vol. 7, No. 46678, pp. 1-9. [cited by applicant]
Allhoff, M. et al. (2013). “Discovering motifs that Induce Sequencing Errors,” BMC Bioinformatics 14(Suppl. 5):S1, pp. 1-10. [cited by applicant]
Alnemri, E.S., et al., Activation of Internucleosomal DNA Cleavage in Human CEM Lymphcytes by Glucocorticoid and Novobiocin, J. Biol. Chem., 1990, 265(28): 17323-17333. [cited by applicant]
Altschul, S.F., et al., Basic Local Alignment Search Tool, 1990, J. Mol. Biol. 215:403-410. [cited by applicant]
Arbeithuber, B. et al. (Jul. 31, 2016). “Artifactual Mutations Resulting from DNA Lesions Limit Detection Levels in Ultrasensitive Sequencing Applications,” DNA Res. 23(6):547-559. [cited by applicant]
Biomek Tips and Labware, Beckman Coulter Life Sciences, 2012, pp. 1-24. [cited by applicant]
Casbon, J.A. et al. (Jul. 2011; e-published on Apr. 13, 2011). “A Method for Counting PCR Template Molecules With Application to Next-Generation Sequencing,” Nucleic Acids Res. 39(12):e81, pp. 1-8. [cited by applicant]
Chen, L. et al. (Feb. 17, 2017). “DNA Damage is a Pervasive Cause of Sequencing Errors, Directly Confounding Variant Identification,” Science 355:752-756, (with supplementary material), twenty eight pages. [cited by applicant]
Cibulskis, K. et al. (Mar. 2013; e-published on Feb. 10, 2013). “Sensitive Detection of Somatic Point Mutations in Impure and Heterogeneous Cancer Samples,” Nat. Biotechnol. 31(3):213-219, twenty one pages. [cited by applicant]
Costello, M. et al. (Apr. 2013; e-published on Jan. 8, 2013). “Discovery and Characterization of Artifactual Mutations in Deep Coverage Targeted Capture Sequencing Data Due to Oxidative DNA Damage During Sample Preparat… [cited by applicant]
De Vlaminck, I. et al. (Oct. 27, 2015; e-published on Oct. 12, 2015). “Noninvasive Monitoring of Infection and Rejection After Lung Transplantation,” Proc. Natl. Acad. Sci. USA 112(43):13336-13341. [cited by applicant]
Fierer et al., “The influence of sex, handedness, and washing on the diversity of hand surface bacteria”, Proc. Nat'l Adad. Sci., vol. 105, Nov. 18, 2008, pp. 17,994-17,999. [cited by applicant]
Gundmundsson et al., “Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility”, Nat Genet, 41:1122-1126, 2009. [cited by applicant]
Hamady, M. et al. (Mar. 2008). “Error-Correcting Barcoded Primers Allow Hundreds of Samples to by Pyrosequenced in Multiplex,” Nature Methods 5(3):235-237, six pages, (with supplementary material), 53 pages. [cited by applicant]
Henikoff, S., et al., Amino acid substitution matrices from protein blocks, Proc. Natl. Acad. Sci., 1992, 89:10915-10919. [cited by applicant]
Higgins, D.G., et al., CLUSTAL: a package for performing multiple sequence alignment on a microcomputer, Gene, 1998, 73:237-244. [cited by applicant]
Hopmans, E.S. et al. (Apr. 29, 2014). “A Programmable Method for Massively Parallel Targeted Sequencing,” Nucleic Acids Res. 42(10):e88, pp. 1-16. [cited by applicant]
Horhota, A., et al., Glycerol Nucleoside Triphosphates: Synthesis and Polymerase Substrate Activities, Organic Letters, 2006, 8(23):5345-5347. [cited by applicant]
Hybridization capture of DNA libraries using xGen Lockdown Probes and Reagents, IDT Integrated DNA Technologies 2015. [cited by applicant]
Illumina, Calculating Percent Passing Filter for Patterned and Nonpatterned Flow Cells, Pub. No. 770-2014-043-B, 2017. [cited by applicant]
Illumina, Quality Scores for Next Generation Sequencing, Pub. No. 770-2011-030, Oct. 31, 2011. [cited by applicant]
Illumina, Understanding Illumina Quality Scores, Pub. No. 770-2012-058, Apr. 23, 2014. [cited by applicant]
International Preliminary Report on Patentability issued on Aug. 15, 2019 in PCT/US2018/013959 (10 pages). [cited by applicant]
International Search Report and Written Opinion issued in corresponding International Application No. PCT/US2017/036836, dated Sep. 5, 2017 (13 pages). [cited by applicant]
International Search Report and Written Opinion issued in PCT/US2018/020744 on May 10, 2018 (4 pages). [cited by applicant]
Jabara, C.B. et al. (Dec. 13, 2011). “Accurate Sampling and Deep Sequencing of the HIV-1 Protease Gene Using a Primer ID,” Proc. Natl. Acad. Sci. U.S.A. 108(50):20166-20171. [cited by applicant]
Kammerer, et al., Oligonucleotide Modifications: Choosing the Right Mod For Your Needs, Integrated DNA Technologies, 2012, 1-5. Obtained online at: https://www.idtdna.com/pages/education/decoded/article/choosing-the-rig… [cited by applicant]
Karlin, S., et al., Applications and statistics for multiple high-scoring segments in molecular sequences, Proc. Natl. Acad. Sci., 1993, 90:5873-5877. [cited by applicant]
Kennedy, S.R. et al. (Nov. 2014; e-published on Oct. 9, 2014). “Detecting Ultralow-Frequency Mutations by Duplex Sequencing,” Nat. Protoc. 9(11):2586-2606, forty pages. [cited by applicant]
Kinde, I. et al. (Jun. 7, 2011). “Detection and Quantification of Rare Mutations With Massively Parallel Sequencing,” Proc. Natl. Acad. Sci. U.S.A. 108(23):9530-9535. [cited by applicant]
Kircher et al. , “Double indexing overcomes inaccuracies in multiplex sequencing on the Illumina platform”, Supplementary pp. 1-17. Nucleic acids research. Jan. 1, 2012; 40(1):e3 pp. 1-8. (Year: 2012). [cited by applicant]
Kircher et al., “Double indexing overcomes inaccuracies in multiplex sequencing on the Illumina platform”, Nucleic acids research. Jan. 1, 2012; 40(1):e3 pp. 1-8. (Year: 2012). [cited by applicant]
Knapp et al., “Generating barcoded libraries for multiplex high-throughput sequencing”, Methods Mol Biol., 2012, 840:155-70. doi: 10.1007/978-1-61779-516-9_19. [cited by applicant]
Kozich et al., “Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform.”, Appl. Environ. Microbial., Sep. 1, 2013; 79(17):511… [cited by applicant]
Krimmel, J.D. et al. (May 24, 2016; e-published on May 5, 2016). “Ultra-Deep Sequencing Detects Ovarian Cancer Cells in Peritoneal Fluid and Reveals Somatic TP53 Mutations in Noncancerous Tissues,” Proc. Natl. Acad. Sci… [cited by applicant]
Krishnan, A.R. et al. (Feb. 24, 2011). “Barcodes for DNA Sequencing With Guaranteed Error Correction and Capability,” Electronics Letters 47(4):236-237. [cited by applicant]
Kunkel, T.A. (Apr. 23, 2004). “DNA Replication Fidelity,” J. Biol. Chem. 279(17):16895-16898. [cited by applicant]
Lanman, R.B. et al. (Oct. 16, 2015). “Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA,” PLoS One 10:e0140712, pp. 1-27. [cited by applicant]
Lefrancois et al., Efficient yeast ChiP-Seq using multiplex short-read DNA sequencing, BMC Genomics, vol. 10, 2009, pp. 1-18. [cited by applicant]
Lovett, Susan T., “The DNA Exonucleases of [cited by applicant]
MacLean et al., “Application of ‘next-generation’ sequencing technologies to microbial genetics”, Nature Reviews Microbiology, vol. 7, Apr. 2009, pp. 287-296. [cited by applicant]
Mardis, E., Next-Generation DNA Sequencing Methods, Annu Rev Genomics Hum Genet 9:387-402, 2008. [cited by applicant]
Margulies, M., et al., Genome Sequencing in Open Microfabricated High Density Picoliter Reactors, Nature 437 7057):376-380, 2005. [cited by applicant]
Mertes, F. et al. (Nov. 2011; e-published on Nov. 26, 2011 ). “Targeted Enrichment of Genomic DNA Regions for Next-Generation Sequencing,” Briefings in Functional Genomics 10(6):374-386. [cited by applicant]
Meyer et al., “Illumina sequencing library preparation for highly multiplexed target capture and sequencing”, Cold Spring Harb Protoc., Jun. 2010;2010(6):pdb.prot5448. doi: 10.1101/pdb.prot5448. [cited by applicant]
Murgha, Yusuf Esmai, “Large-Scale Generation of Synthetic DNA Libraries: Sequence-Specific Priming of Reverse Transcription”, PhD diss., 2012. [cited by applicant]
Myllykangas, S. et al. (Nov. 2011; e-published on Oct. 23, 2011). “Efficient Targeted Resequencing of Human Germline and Cancer Genomes by Oligonucleotide-Selective Sequencing,” Nat Biotechnol. 29(11):1024-1027. [cited by applicant]
Neb, Restriction Enzyme Digestion Products, New England Biolabs, 2021, 1-9. Obtained online at: https://www.neb.com/ plications/cloning-and-synthetic-biology/dna-preparation/restriction-enzyme-digestion/products on Aug.… [cited by applicant]
Needleman, S.B. et al. (Mar. 1970). “A General Method Applicable to the Search for Similarities in the Amino Acid Sequence of Two Proteins,” Journal of Molecular Biology 48(3):443-453. [cited by applicant]
Newman, A.M. (2016; e-published on Mar. 28, 2016). “Integrated Digital Error Suppression for Improved Detection of Circulating Tumor DNA,” Nature Biotechnology 34:547-555 (includes Supplementary material). [cited by applicant]
Nikiforov et al, “The use of phosphorothioate primers and exonuclease hydrolysis for the preparation of single-stranded PCR products and their detection by solid-phase hybridization”, Genome Research. Apr. 1, 1994; 3(5)… [cited by applicant]
Nikooienejad et al., “Fast DNA Barcode Generating Algorithm Using Radix Coding Method”, IEEE International Workshop on Genomic Signal Processing and Statistics (GENSIPS), Dec. 2012, pp. 26-30. [cited by applicant]
NimbleGen Seq EZ Library SR Users Guide, Roche, 2014. [cited by applicant]
O'Roak, B.J. et al. (Dec. 21, 2012; e-published on Nov. 15, 2012). “Multiplex Targeted Sequencing Identifiers Recurrently Mutated Genes in Autism Spectrum Disorders,” Science 338(6114):1619-1622, thirteen pages. [cited by applicant]
Pearson, W.R., et al., Improved tools for biological sequence comparison, Proc. Natl. Acad. Sci., 1988, 85:2444-2448. [cited by applicant]
Peng et al., “Reducing amplification artifacts in high multiplex amplicon sequencing by using molecular barcodes”, BMC genomics. Dec. 2015; 16(1):589 pp. 1-12. [cited by applicant]
Richards, O.C., et al., Chemical Mechanism of Sonic, Acid, Alkaline and Enzymic Degradation of DNA, J. Mol. Biol., 1965, 11:327-340. [cited by applicant]
Samorodnitsky et al. “Comparison of custom capture for targeted next-generation DNA sequencing,” J Mol Diagn, Jan. 1, 2015 (Jan. 1, 2015), vol. 17, pp. 64-75. [cited by applicant]
Schirmer, M. et al. (Mar. 11, 2016). “Illumina Error Profiles: Resolving Fine-Scale Variation in Metagenomics Sequencing Data,” BMC Bioinformatics 17:125, pp. 1-15. [cited by applicant]
Schmitt et al., “Detection of ultra-rare mutations by next-generation sequencing”, Proceedings National Academy of Sciences, 2012, pp. 1-6. [cited by applicant]
Schmitt, M.W. et al. (May 2015; Apr. 6, 2015). “Sequencing Small Genomic Targets with High Efficiency and Extreme Accuracy,” Nat. Methods 12(5):423-425, nine pages. [cited by applicant]
Schmitt, M.W. et al. (Sep. 4, 2012; e-published on Aug. 1, 2012). “Detection of Ultra-Rare Mutations by Next-Generation Sequencing,” Proc. Natl. Acad. Sci. U.S.A. 109(36) :14508-14513. [cited by applicant]
Schwarzenbach, H. et al. (Jun. 2011; e-published on May 12, 2011). “Cell-Free Nucleic Acids as Biomarkers in Cancer Patients,” Nature Reviews Cancer 11(6):426-437. [cited by applicant]
Sehnert et al., “Optimal Detection of Fetal Chromosomal Abnormalities by Massively Parallel DNA Sequencing of Cell-Free Fetal DNA from Maternal Blood”, Clinical Chemistry, vol. 57, No. 7, 2011, pp. 1-8. [cited by applicant]
Soni, G., et al., Progress toward Ultrafast DNA Sequencing Using Solid-State Nanopores, Clin Chem 53:1996-2001, 2007. [cited by applicant]
Talevich, E. et al. (Apr. 21, 2016). “CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing,” PLoS Comput. Biol. 12(4):e1004873, pp. 1-18. [cited by applicant]
Travers, K.J. et al. (201O; e-published on Jun. 22, 2010). “A Flexible and Efficient Template Format for Circular Consensus Sequencing and SNP Detection,” Nucleic Acids Research 38(15):e159, pp. 1-8. [cited by applicant]
Troutt, A., et al., Ligation-anchored PCR: A simple amplification technique with single-sided specificity, Proc Natl Acad Sci USA 89:9823-9825, 1992. [cited by applicant]
Turner et al., “Massively parallel exon capture and library-free resequencing across 16 genomes”, Nat. Methods, 6:315-316, 2009. [cited by applicant]
Wong et al., “Multiplex Illumina Sequencing Using DNA Barcoding”, Current Protocols in Molecular Biology, Jan. 2013, pp. 7.11.1-7.11.11. [cited by applicant]
Zhong, S. et al. (2011 ). “High-Throughput Illumina Strand-Specific RNA Sequencing Library Preparation,” Cold Spring Harbor Protocols 2011 (8):940-949. [cited by applicant]
Zimmermann, B. et al. (Dec. 2012; e-published on Oct. 30, 2012). “Noninvasive Prenatal Aneuploidy Testing of Chromosomes 13, 18, 21, X, and Y, Using Targeted Sequencing of Polymorphic Loci,” Prenat. Diagn. 32(13):1233-1… [cited by applicant]